Bio-Rad Introduces New Pro-Human Diabetes Assay Panel

Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced new Bio-Plex Pro™ Human Diabetes Assay Panels for Bio-Rad’s Bio-Plex^® suspension array system.

Offered as one multiplex and two singleplex assays designed to achieve optimal working assay ranges, the new pro-human diabetes assay delivers accurate and reproducible multiplex measurements of human diabetes and obesity markers.

Product Features

• The pro-human assay panel consists of a premixed 12-plex of analytes (C-Peptide, ghrelin, GIP, GLP-1, glucagon, IL6, insulin, leptin, PAi-1, resistin, TNF-a, and visfatin) that work with magnetic beads, pre-blended detection antibodies, standards and controls. The singleplex assays (adiponectin and adipsin) may be mixed together to form a 2-plex assay.
• The reagent kit includes an assay buffer, wash buffer, streptavidin-PE, 96-well filter plate, sealing tape, and panel specific instructions required to prepare assays and acquire data.
• The diluents kit enables the researcher to choose the appropriate diluents kit for diluting samples, standards and controls.

All three Bio-Plex pro-human diabetes assays were validated using real patient samples.